T 1326/18 of 22.04.2021
- European Case Law Identifier
- ECLI:EP:BA:2021:T132618.20210422
- Date of decision
- 22 April 2021
- Case number
- T 1326/18
- Petition for review of
- -
- Application number
- 04806748.2
- IPC class
- A61K 31/505C07D 401/04
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- NOVEL POLYMORPHIC FORM OF IMATINIB MESYLATE AND A PROCESS FOR ITS PREPARATION
- Applicant name
- Natco Pharma Limited
- Opponent name
- Onsagers AS
Gizinska-Schohe, Malgorzata - Board
- 3.3.02
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 123(3)European Patent Convention Art 54(3)European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 12(2)Rules of procedure of the Boards of Appeal Art 12(4)Rules of procedure of the Boards of Appeal Art 25(2)
- Keywords
- Amendments - intermediate generalisation
Novelty
Sufficiency of disclosure
Inventive step
Late-filed document
Late-filed auxiliary requests
Late-filed objection
Remittal - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the first instance with the order to maintain the patent on the basis of the claims according to the fourth auxiliary request, and a description and figures to be adapted thereto.